Rosalind Advisors, Inc. 13F 持仓 · 2026年Q2
Rosalind Advisors 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 29 只证券，申报市值合计 2.69 亿美元。前几大持仓：DCTH（15.44%）、FENC（12.73%）、XERS（8.56%）。本季前 25 大持仓中：新建仓 2 只、增持 7 只、减持 10 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | $41.6M | 15.44% | 3.3M | 持平 |
| 2 | FENC | FENNEC PHARMACEUTICALS INC | $34.3M | 12.73% | 3.2M | 增持 |
| 3 | XERS | XERIS BIOPHARMA HOLDINGS INC | $23.0M | 8.56% | 2.9M | 减持 |
| 4 | SVRA | SAVARA INC | $19.6M | 7.27% | 3.2M | 减持 |
| 5 | VSTM | VERASTEM INC | $15.2M | 5.66% | 4.0M | 增持 |
| 6 | XFOR | X4 PHARMACEUTICALS INC | $15.0M | 5.58% | 3.2M | 持平 |
| 7 | EYPT | EYEPOINT PHARMACEUTICALS INC | $14.1M | 5.25% | 988,230 | 减持 |
| 8 | HELP | CYBIN INC | $12.9M | 4.80% | 2.0M | 增持 |
| 9 | VOR | VOR BIOPHARMA INC | $11.9M | 4.44% | 648,600 | 减持 |
| 10 | PCVX | VAXCYTE INC | $11.6M | 4.32% | 200,000 | 减持 |
| 11 | MDWD | MEDIWOUND LTD | $11.0M | 4.09% | 749,054 | 持平 |
| 12 | CLDX | CELLDEX THERAPEUTICS INC | $7.4M | 2.76% | 200,000 | 减持 |
| 13 | BCRX | BIOCRYST PHARMACEUTICALS INC | $7.2M | 2.68% | 721,504 | 减持 |
| 14 | PROF | PROFOUND MEDICAL CORP | $5.5M | 2.05% | 828,118 | 持平 |
| 15 | TLPH | TALPHERA INC | $5.3M | 1.98% | 5.2M | 增持 |
| 16 | AVIR | ATEA PHARMACEUTICALS INC | $5.0M | 1.85% | 1.1M | 减持 |
| 17 | MYO | MYOMO INC | $3.8M | 1.41% | 3.6M | 减持 |
| 18 | OVID | OVID THERAPEUTICS INC | $3.0M | 1.11% | 1.1M | 持平 |
| 19 | NRXS | NEURAXIS INC | $3.0M | 1.10% | 508,055 | 增持 |
| 20 | ABVX | ABIVAX SA | $2.8M | 1.03% | 20,869 | 新建仓 |
| 21 | NSPR | INSPIREMD INC | $2.7M | 1.02% | 3.9M | 持平 |
| 22 | RGNT | REGENTIS BIOMATERIALS LTD | $2.5M | 0.92% | 701,685 | 增持 |
| 23 | SLS | SELLAS LIFE SCIENCES GROUP INC | $2.3M | 0.86% | 568,700 | 新建仓 |
| 24 | PYPD | POLYPID LTD | $2.0M | 0.73% | 389,455 | 减持 |
| 25 | BFRI | BIOFRONTERA INC | $1.2M | 0.45% | 1.3M | 增持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR